Shifa International Hospitals Limited (PSX:SHFA)
Pakistan
· Delayed Price · Currency is PKR 482.11
-7.18 (-1.47%)
At close: Apr 28, 2026
PSX:SHFA Revenue
Shifa International Hospitals had revenue of 7.39B PKR in the quarter ending March 31, 2026, with 6.40% growth. This brings the company's revenue in the last twelve months to 29.84B, up 12.03% year-over-year. In the fiscal year ending June 30, 2025, Shifa International Hospitals had annual revenue of 27.97B with 18.74% growth.
Revenue (ttm)
29.84B
Revenue Growth
+12.03%
P/S Ratio
1.02
Revenue / Employee
5.30M
Employees
5,627
Market Cap
30.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 27.97B | 4.41B | 18.74% |
| Jun 30, 2024 | 23.55B | 3.85B | 19.57% |
| Jun 30, 2023 | 19.70B | 3.51B | 21.66% |
| Jun 30, 2022 | 16.19B | 1.97B | 13.84% |
| Jun 30, 2021 | 14.22B | 1.96B | 16.02% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GlaxoSmithKline Pakistan | 65.90B |
| Abbott Laboratories (Pakistan) | 75.40B |
| The Searle Company | 33.26B |
| AGP Limited | 28.89B |
| Highnoon Laboratories | 27.71B |
| Citi Pharma | 14.10B |
| Ferozsons Laboratories | 22.22B |
| Macter International | 11.58B |